French Industry Welcomes Moves To Speed Up Access To Innovative Drugs
Executive Summary
A French government/industry discussion forum has come up with concrete plans for accelerating access to innovative medicines by streamlining clinical trial approval and price negotiations.
You may also be interested in...
Over-Regulation Is Damaging French Pharma Sector
Leem says “Inconsistent and unpredictable” policies are hitting industry’s competitiveness and limiting patients’ access to new medicines.
French Gene & Cell Therapy Trials To Get Own Fast-Track Approval Process
Experimental gene and cell therapy products are to get a boost from the French regulator in the form of a new fast-track clinical trial approval process. This is the third accelerated pathway to be introduced as part of efforts to speed up patient access to new medicines.
French 2019 Budget A Mix Of Good And Bad News For Pharma
The French government is proposing to extend the use of the temporary use authorization system for unapproved drugs and to increase the rate of generic prescribing. It has also set a low threshold for the increase in pharmaceutical sales that triggers the payback mechanism.